Guardian Drug Co. Inc. vs Harbin Jixianglong Biotech Co., Ltd.: FDA Enforcement Comparison

Guardian Drug Co. Inc. has been the subject of 23 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Harbin Jixianglong Biotech Co., Ltd..

Guardian Drug Co. Inc.: 0 warning letters, 23 recalls, 0 approval records, 0 Form 483s.

Harbin Jixianglong Biotech Co., Ltd.: 1 warning letter, 0 recalls, 0 approval records, 0 Form 483s.

Side by side

Guardian Drug Co. Inc. — Warning letters0

Harbin Jixianglong Biotech Co., Ltd. — Warning letters1

Guardian Drug Co. Inc. — Recalls23

Harbin Jixianglong Biotech Co., Ltd. — Recalls0

Guardian Drug Co. Inc. — Approval records0

Harbin Jixianglong Biotech Co., Ltd. — Approval records0

Guardian Drug Co. Inc. — Form 483s0

Harbin Jixianglong Biotech Co., Ltd. — Form 483s0

Timeline

Guardian Drug Co. Inc.

Most recent FDA action: June 10, 2026

Full history →

Harbin Jixianglong Biotech Co., Ltd.

Most recent FDA action: May 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Guardian Drug Co. Inc. vs Harbin Jixianglong Biotech Co., Ltd.: FDA Enforcement Comparison." Argus HQ, accessed July 13, 2026. https://argushq.ai/compare/guardian-drug-co-inc-vs-harbin-jixianglong-biotech-co-ltd

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗